These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34517465)

  • 41. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.
    Schüttler CG; Caspari G; Jursch CA; Willems WR; Gerlich WH; Schaefer S
    Lancet; 2000 Jan; 355(9197):41-2. PubMed ID: 10615893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.
    Mison L; Seed CR; Margaritis AR; Hyland C;
    Vox Sang; 2003 Jan; 84(1):11-9. PubMed ID: 12542729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.
    Ross RS; Viazov SO; Hoffmann S; Roggendorf M
    J Clin Lab Anal; 2001; 15(6):308-13. PubMed ID: 11793430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of HCV antibody-negative donations: Saudi experience with nucleic acid testing.
    Hajeer AH; Al Gharawi K; Al Rayes W; Qasem L; Merenkov Z; Al Balwi M
    Br J Biomed Sci; 2008; 65(2):103-4. PubMed ID: 19055115
    [No Abstract]   [Full Text] [Related]  

  • 46. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A method for rapid detection and genotype identification of hepatitis C virus 1-6 by one-step reverse transcription loop-mediated isothermal amplification.
    Nyan DC; Swinson KL
    Int J Infect Dis; 2016 Feb; 43():30-36. PubMed ID: 26686938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methods of study of the hepatitis C virus genome. Diagnostic tools in human pathology].
    Pawlotsky JM
    Vet Res; 1995; 26(1):3-10. PubMed ID: 7711774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-radioactive hybridization with hepatitis C virus-specific probes created during polymerase chain reaction: a fast and simple procedure to verify hepatitis C virus infection.
    Geiger CP; Caselmann WH
    J Hepatol; 1992 Jul; 15(3):387-90. PubMed ID: 1333000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Viral safety of biologicals: evaluation of hepatitis C virus (HCV) nucleic acid amplification test (NAT) assay and development of concentration method of HCV for sensitive detection by NAT].
    Uchida E; Yamaguchi T
    Yakugaku Zasshi; 2010 Feb; 130(2):163-9. PubMed ID: 20118638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid visual detection of hepatitis C virus using a reverse transcription loop-mediated isothermal amplification assay.
    Hongjaisee S; Doungjinda N; Khamduang W; Carraway TS; Wipasa J; Debes JD; Supparatpinyo K
    Int J Infect Dis; 2021 Jan; 102():440-445. PubMed ID: 33130211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
    Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
    Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosing acute hepatitis C in HIV-infected patients: nucleic acid testing compared with antibody and antigen-antibody detecting methods.
    Nastouli E; Thomson EC; Karayiannis P; Main J; McClure M; Muir D
    J Clin Virol; 2009 Jan; 44(1):78-80. PubMed ID: 18986830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genotyping and RNA quantification of hepatitis C virus. ].
    Myrmel H; Kursetgjerde T
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2448. PubMed ID: 14508531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of manual and automated nucleic acid isolation methods for HBV-DNA and HCV-RNA assays.
    Yagmur G; Altun HU; Gökahmetoglu S; Basok E
    Infez Med; 2015 Sep; 23(3):247-52. PubMed ID: 26397294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
    Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
    Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.
    Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K;
    Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: external quality assessment.
    Gentili G; Pisani G; Bisso G; Cristiano K; Wirz M; Mele C;
    Vox Sang; 2001 Oct; 81(3):143-7. PubMed ID: 11703855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
    O'Brien SF; Fan W; Scalia V; Goldman M; Fearon MA; Vamvakas EC
    Vox Sang; 2006 Apr; 90(3):204. PubMed ID: 16507022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.